Pickard; Richard Todd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pickard; Richard Todd.The latest application filed is for "growth differentiation factor 15 agonist compounds and methods of using the same".

Company Profile

1.9.12

Pickard; Richard Todd - Noblesville IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Growth differentiation factor 15 agonist compounds and methods of using the same Grant 11,104,711 - Gonciarz , et al. August 31, 2	2021-08-31
Growth Differentiation Factor 15 Agonist Compounds And Methods Of Using The Same App 20190309033 - Gonciarz; Malgorzata Donata ; et al.	2019-10-10
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,178,528 - Hipskind , et al. May 15, 2	2012-05-15
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,008,301 - Beavers , et al. August 30, 2	2011-08-30
Histamine H3 receptor agents, preparation and therapeutic uses Grant 8,008,296 - Beavers , et al. August 30, 2	2011-08-30
Pyrrolidine derivatives as histamine H3 receptor antagonists Grant 7,951,826 - Beavers , et al. May 31, 2	2011-05-31
Histamine H3 receptor antagonists, preparation and therapeutic uses Grant 7,902,191 - Beavers , et al. March 8, 2	2011-03-08
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100160319 - Beavers; Lisa Selsam ; et al.	2010-06-24
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100160406 - Hipskind; Philip Arthur ; et al.	2010-06-24
Histamine H3 receptor agents, preparation and therapeutic uses Grant 7,696,234 - Beavers , et al. April 13, 2	2010-04-13
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20100048580 - Beavers; Lisa Selsam ; et al.	2010-02-25
Oxazole derivatives as histamine H3 receptor agents, preparation and therapeutic uses Grant 7,666,871 - Beavers , et al. February 23, 2	2010-02-23
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20090118254 - Beavers; Lisa Selsam ; et al.	2009-05-07
Pyrrolidine Derivatives as Histamine H3 Receptor Antagonists App 20080207732 - Beavers; Lisa Selsam ; et al.	2008-08-28
Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses Grant 7,314,937 - Beavers , et al. January 1, 2	2008-01-01
Histamine H3 Receptor Agents, Preparation And Therapeutic Uses App 20070208024 - Beavers; Lisa Selsam ; et al.	2007-09-06
Oxazole derivatives as histamine h3 receptor agents,preparation and therapeutic uses App 20070197604 - Beavers; Lisa Selsam ; et al.	2007-08-23
Histamine h3 receptor antagonists, preparation and therapeutic uses App 20070155754 - Beavers; Lisa Selsam ; et al.	2007-07-05
Histamine h3 receptor antagonists, preparation and therapeutic uses App 20060167046 - Beavers; Lisa Selsam ; et al.	2006-07-27
Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses App 20060089347 - Gadski; Robert Alan ; et al.	2006-04-27
Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses App 20040110748 - Beavers, Lisa Selsam ; et al.	2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.